Specific pathogen-free status alters immunophenotype in rhesus macaques: implications for the study of simian immunodeficiency virus.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 3186704)

Published in AIDS Res Hum Retroviruses on April 03, 2011

Authors

Rosemary V Santos1, Kuei-Chin Lin, Keith Mansfield, Lynn M Wachtman

Author Affiliations

1: New England Primate Research Center, Harvard Medical School, Southborough, Massachusetts 01772, USA.

Articles cited by this

Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol (2004) 17.54

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science (1995) 17.42

Hay fever, hygiene, and household size. BMJ (1989) 15.94

A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells. J Immunol (1981) 10.92

The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med (2002) 9.26

Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood (2004) 7.09

Development and homeostasis of T cell memory in rhesus macaque. J Immunol (2002) 6.88

The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection. J Virol (1997) 3.77

Homeostasis of memory T cells. Immunol Rev (2006) 3.69

A herpesvirus of rhesus monkeys related to the human Kaposi's sarcoma-associated herpesvirus. J Virol (1997) 3.10

Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS. J Clin Invest (2005) 3.08

Immune activation is a dominant factor in the pathogenesis of African AIDS. Immunol Today (1995) 2.84

IL-15 induces CD4 effector memory T cell production and tissue emigration in nonhuman primates. J Clin Invest (2006) 2.41

Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10. Proc Natl Acad Sci U S A (2000) 2.24

Safety and immunologic effects of IL-15 administration in nonhuman primates. Blood (2009) 2.00

Serologic and immunologic studies in patients with AIDS in North America and Africa. The potential role of infectious agents as cofactors in human immunodeficiency virus infection. JAMA (1987) 1.98

Natural pathogens of laboratory mice, rats, and rabbits and their effects on research. Clin Microbiol Rev (1998) 1.88

Induction of B cell hyperplasia in simian immunodeficiency virus-infected rhesus macaques with the simian homologue of Kaposi's sarcoma-associated herpesvirus. J Exp Med (1999) 1.67

Protection against simian/human immunodeficiency virus (SHIV) 89.6P in macaques after coimmunization with SHIV antigen and IL-15 plasmid. Proc Natl Acad Sci U S A (2007) 1.60

Profound CD4+/CCR5+ T cell expansion is induced by CD8+ lymphocyte depletion but does not account for accelerated SIV pathogenesis. J Exp Med (2009) 1.51

Induction of CD4+ T-cell anergy and apoptosis by activated human B cells. Blood (2008) 1.49

IL-15 treatment during acute simian immunodeficiency virus (SIV) infection increases viral set point and accelerates disease progression despite the induction of stronger SIV-specific CD8+ T cell responses. J Immunol (2008) 1.49

Intrinsic susceptibility of rhesus macaque peripheral CD4(+) T cells to simian immunodeficiency virus in vitro is predictive of in vivo viral replication. J Virol (2000) 1.47

IL-10 is induced during HIV-1 infection and is capable of decreasing viral replication in human macrophages. J Immunol (1994) 1.46

Experimental infection of rhesus and pig-tailed macaques with macaque rhadinoviruses. J Virol (1999) 1.41

AIDS as immune system activation: a model for pathogenesis. Clin Exp Immunol (1988) 1.39

Cytotoxic T-lymphocyte responses to cytomegalovirus in normal and simian immunodeficiency virus-infected rhesus macaques. J Virol (1996) 1.31

Experimental coinfection of rhesus macaques with rhesus cytomegalovirus and simian immunodeficiency virus: pathogenesis. J Virol (2002) 1.29

Higher macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels from CD8+ T cells are associated with asymptomatic HIV-1 infection. Proc Natl Acad Sci U S A (2000) 1.26

Therapeutic vaccination with simian immunodeficiency virus (SIV)-DNA + IL-12 or IL-15 induces distinct CD8 memory subsets in SIV-infected macaques. J Immunol (2008) 1.22

Interleukin-10 promoter polymorphisms influence HIV-1 susceptibility and primary HIV-1 pathogenesis. J Infect Dis (2009) 1.21

The human immunomodulatory CD25+ B cell population belongs to the memory B cell pool. Scand J Immunol (2007) 1.16

Increased IL-15 production is associated with higher susceptibility of memory CD4 T cells to simian immunodeficiency virus during acute infection. J Immunol (2009) 1.14

Cloning of the rhesus lymphocryptovirus viral capsid antigen and Epstein-Barr virus-encoded small RNA homologues and use in diagnosis of acute and persistent infections. J Clin Microbiol (2000) 1.14

Persistent MHV (mouse hepatitis virus) infection reduces the incidence of diabetes mellitus in non-obese diabetic mice. Diabetologia (1991) 1.13

The replicative capacity of rhesus macaque peripheral blood mononuclear cells for simian immunodeficiency virus in vitro is predictive of the rate of progression to AIDS in vivo. J Gen Virol (2000) 1.12

Alopecia in Rhesus macaques correlates with immunophenotypic alterations in dermal inflammatory infiltrates consistent with hypersensitivity etiology. J Med Primatol (2010) 1.10

Influence of environmental viral agents on frequency and tempo of diabetes mellitus in BB/Wor rats. Diabetes (1991) 1.07

Generation of CD8 suppressor factor and beta chemokines, induced by xenogeneic immunization, in the prevention of simian immunodeficiency virus infection in macaques. Proc Natl Acad Sci U S A (1998) 1.07

IL-10 synergizes with multiple cytokines in enhancing HIV production in cells of monocytic lineage. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.03

Specific pathogen-free macaques: definition, history, and current production. ILAR J (2008) 1.03

Phenotypic and functional characterization of human CD25+ B cells. Immunology (2006) 1.02

Simian retrovirus infections: potential confounding variables in primate toxicology studies. Toxicol Pathol (2003) 1.02

Interleukin-10 enhances tumor necrosis factor-alpha activation of HIV-1 transcription in latently infected T cells. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.02

Induction of HIV-1 replication by type 1-like cytokines, interleukin (IL)-12 and IL-15: effect on viral transcriptional activation, cellular proliferation, and endogenous cytokine production. J Clin Immunol (1998) 1.01

Suppression of development of diabetes in NOD mice by lactate dehydrogenase virus infection. J Autoimmun (1992) 0.94

IL-15 and HIV infection: lessons for immunotherapy and vaccination. Curr HIV Res (2005) 0.94

Viruses as therapeutic agents. II. Viral reassortants map prevention of insulin-dependent diabetes mellitus to the small RNA of lymphocytic choriomeningitis virus. J Exp Med (1990) 0.91

IL-10 cooperates with TNF-alpha to activate HIV-1 from latently and acutely infected cells of monocyte/macrophage lineage. J Immunol (1996) 0.90

Environmental modulation of autoimmune arthritis involves the spontaneous microbial induction of T cell responses to regulatory determinants within heat shock protein 65. J Immunol (2001) 0.87

The inhibition of HIV replication in monocytes by interleukin 10 is linked to inhibition of cell differentiation. AIDS Res Hum Retroviruses (1996) 0.85

Comparative pathobiology of Kaposi sarcoma-associated herpesvirus and related primate rhadinoviruses. Comp Med (2008) 0.84

Coinfection of macaques with simian immunodeficiency virus and simian T cell leukemia virus type I: effects on virus burdens and disease progression. J Infect Dis (1999) 0.82

Opportunistic infections in immunologically compromised nonhuman primates. ILAR J (2008) 0.79

Constitutive cytokine release by simian T-cell lymphotrophic virus type I (STLV-I) and human T-cell lymphotrophic virus types I/II (HTLV-I/II) transformed cell lines. J Med Primatol (1996) 0.79

Articles by these authors

Pathogenic simian immunodeficiency virus infection is associated with expansion of the enteric virome. Cell (2012) 3.22

Heart and skeletal muscle are targets of dengue virus infection. Pediatr Infect Dis J (2010) 1.67

Mucosal priming of simian immunodeficiency virus-specific cytotoxic T-lymphocyte responses in rhesus macaques by the Salmonella type III secretion antigen delivery system. J Virol (2003) 1.60

Reproduction in captive common marmosets (Callithrix jacchus). Comp Med (2003) 1.59

Lassa virus infection in experimentally infected marmosets: liver pathology and immunophenotypic alterations in target tissues. J Virol (2007) 1.41

Clinical outcome of henipavirus infection in hamsters is determined by the route and dose of infection. J Virol (2011) 1.40

Pneumonitis and multi-organ system disease in common marmosets (Callithrix jacchus) infected with the severe acute respiratory syndrome-associated coronavirus. Am J Pathol (2005) 1.33

Clinical care and diseases of the common marmoset (Callithrix jacchus). Comp Med (2003) 1.30

Determinants of increased replicative capacity of serially passaged simian immunodeficiency virus with nef deleted in rhesus monkeys. J Virol (2003) 1.28

Alopecia in Rhesus macaques correlates with immunophenotypic alterations in dermal inflammatory infiltrates consistent with hypersensitivity etiology. J Med Primatol (2010) 1.10

Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates. Vaccine (2008) 1.09

Imidazoquinoline Toll-like receptor 8 agonists activate human newborn monocytes and dendritic cells through adenosine-refractory and caspase-1-dependent pathways. J Allergy Clin Immunol (2012) 1.09

High-performance metabolic profiling of plasma from seven mammalian species for simultaneous environmental chemical surveillance and bioeffect monitoring. Toxicology (2012) 1.08

GB virus B infection of the common marmoset (Callithrix jacchus) and associated liver pathology. J Gen Virol (2004) 1.07

Non-human primate model of Kaposi's sarcoma-associated herpesvirus infection. PLoS Pathog (2009) 1.06

Protective efficacy of a single immunization of a chimeric adenovirus vector-based vaccine against simian immunodeficiency virus challenge in rhesus monkeys. J Virol (2009) 1.06

A small nonhuman primate model for filovirus-induced disease. Virology (2011) 1.03

Metabolome-wide association study of phenylalanine in plasma of common marmosets. Amino Acids (2014) 0.92

An SHIV DNA/MVA rectal vaccination in macaques provides systemic and mucosal virus-specific responses and protection against AIDS. AIDS Res Hum Retroviruses (2004) 0.92

Alterations in expression of monocyte chemotactic protein-1 in the simian immunodeficiency virus model of disseminated Mycobacterium avium complex. J Infect Dis (2004) 0.91

Differential expression of GLUT2 in pancreatic islets and kidneys of New and Old World nonhuman primates. Am J Physiol Regul Integr Comp Physiol (2008) 0.90

Monoclonal antibodies against Enterocytozoon bieneusi of human origin. Clin Diagn Lab Immunol (2005) 0.90

Depo-Provera does not alter disease progression in SIVmac-infected female Chinese rhesus macaques. AIDS Res Hum Retroviruses (2010) 0.89

Septicemia and peritonitis in a colony of common marmosets (Callithrix jacchus) secondary to Klebsiella pneumoniae infection. Contemp Top Lab Anim Sci (2005) 0.86

Characterization of plasma thiol redox potential in a common marmoset model of aging. Redox Biol (2013) 0.85

The efficacy of T cell-mediated immune responses is reduced by the envelope protein of the chimeric HIV-1/SIV-KB9 virus in vivo. J Immunol (2008) 0.85

Influence of mismatch of Env sequences on vaccine protection by live attenuated simian immunodeficiency virus. J Virol (2013) 0.85

Model of traumatic spinal cord injury in Macaca fascicularis: similarity of experimental lesions created by epidural catheter to human spinal cord injury. J Med Primatol (2006) 0.82

Pharmacokinetics of OpdA, an organophosphorus hydrolase, in the African green monkey. Biochem Pharmacol (2010) 0.79

The genetic epidemiology of spontaneous endometriosis in the rhesus monkey. Ann N Y Acad Sci (2002) 0.78

SIV-specific CD8+ T cells are enriched in female genital mucosa of rhesus macaques and express receptors for inflammatory chemokines. Am J Reprod Immunol (2011) 0.77

Naturally occurring Tyzzer's disease in cotton-top tamarins (Saguinus oedipus). Comp Med (2007) 0.77

Natural iminosugar derivatives of 1-deoxynojirimycin inhibit glycosylation of hepatitis viral envelope proteins. J Microbiol (2007) 0.77

Alternative activation of macrophages in rhesus macaques (Macaca mulatta) with endometriosis. Comp Med (2012) 0.77

Treatment of giardiasis in common marmosets (Callithrix jacchus) with tinidazole. Comp Med (2009) 0.76

Retrospective clinical and molecular analysis of conditioned laboratory dogs (Canis familiaris) with serologic reactions to Ehrlichia canis, Borrelia burgdorferi, and Rickettsia rickettsii. J Am Assoc Lab Anim Sci (2008) 0.75

Correction: Metabolic Characterization of the Common Marmoset (Callithrix jacchus). PLoS One (2016) 0.75

The effect of micronutrient supplementation on disease progression and death in simian immunodeficiency virus-infected juvenile male rhesus macaques. J Infect Dis (2005) 0.75

Cloning and characterization of rhesus IL-18 binding protein, a natural antagonist to IL-18. Cytokine (2010) 0.75

Electromyographic telemetry in the development of humane primate model of spinal cord injury. J Med Primatol (2006) 0.75

Compound Property Optimization in Drug Discovery Using Quantitative Surface Sampling Micro Liquid Chromatography with Tandem Mass Spectrometry. Anal Chem (2016) 0.75